[치매 명의] 前 삼성서울병원 신경과 나덕렬 교수

치매 명의로 알려진 前 삼성서울병원 신경과 나덕렬 교수님입니다.

 

나덕렬 교수

 

학력

1986. 전남대학교 의과대학 (의학사)

1989. 전남대학교 대학원 (의학석사)

1996. 전남대학교 대학원 (의학박사)

 

 

 

경력

2019.04 ~ 성균관대학교 의과대학 신경과학 주임교수

2009.12 ~ 성균관의대 삼성서울병원 신경과 부교수

2002.03 ~ Department of Neurology

2013.08 ~ 2019.03 성균관의대 삼성서울병원 신경과 교수

2009.09 ~ 2013.08 Clinical fellow

2009.09 ~ 2013.07 삼성서울병원 신경과 전문의

1997.03 ~ 2002.02 University of Florida

1994.12 ~ 1997.02 Research and clinical fellow

1993.12 ~ 1994.12 London Canada Department of Neurology

1993.01 ~ 1993.12 University of Western Ontario

1991.01 ~ 1992.10 서울대학교병원 임상교수요원 - 보라매 병원 근무

1989.03 ~ 1990.12 서울대학교병원 신경과 전임의 - 보라매 병원 근무

1989.02 신경과 전문의 자격 취득

1986.05 ~ 1989.02 서울대학교 병원 신경과 전공의 과정 수료

1982.03 ~ 1983.02 서울대학교 병원 인턴 과정

 

저서

도서출판 뇌미인

뇌미인 트레이닝 365 2권

 

논문

J Alzheimers Dis. 2017;55(1):283-292.

Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study

Myung W11, Lee C1, Park JH1, Woo SY2, Kim S2, Kim S1, Chung JW1, Kang HS3, Lim SW1,3, Choi J1, Na DL4, Kim SY5, Lee JH6, Han SH7, Choi SH8, Kim SY9, Carroll BJ10, Kim DK1.

 

J Alzheimers Dis. 2017;57(3):711-716. doi: 10.3233/JAD-161139.

F-18-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy

Kim HJ11,2, Cho H3, Werring DJ4, Jang YK1,2, Kim YJ1,2,5, Lee JS6, Lee J1,2,7, Jun S1,2, Park S1,2, Ryu YH8, Choi JY8, Cho YS9, Moon SH9, Na DL1,2,10, Lyoo CH3, Seo SW1,2,10,11.

 

Brain. 2017 Apr 1;140(4):1107-1116. doi: 10.1093/brain/awx003.

MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden

Banerjee G11, Kim HJ2,3, Fox Z4, Jager HR5, Wilson D1, Charidimou A1, Na HK2, Na DL2,3, Seo SW2,3, Werring DJ1.

 

PLoS One. 2017 Mar 22;12(3):e0171803. doi: 10.1371/journal.pone.0171803. eCollection 2017.

Agreement between functional connectivity and cortical thickness-driven correlation maps of the medial frontal cortex

Park H11,2, Park YH3, Cha J3, Seo SW4, Na DL4, Lee JM3.

 

Australas J Ageing. 2017 Mar;36(1):46-51. doi: 10.1111/ajag.12374.

Behavioural and neuropsychiatric disturbance in three clinical subtypes of frontotemporal dementia: A Clinical Research Center for Dementia of South Korea-FTD Study

Park MH11, Kim EJ2, Park KW3, Kwon JC4, Ku BD5, Han SH6, Kim S7, Yang DW8, Na DL9, Choi SH10.

 

Geriatr Gerontol Int. 2017 Mar;17(3):494-499. doi: 10.1111/ggi.12754. Epub 2016 Apr 25.

Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)

Yoon SJ11, Choi SH2, Na HR3, Park KW4, Kim EJ5, Han HJ6, Lee JH7, Shim YS8, Na DL9.

 

Sci Rep. 2017 Mar 9;7:43270. doi: 10.1038/srep43270.

Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns

Park JY11, Na HK2, Kim S2, Kim H2, Kim HJ3,4, Seo SW3,4, Na DL3,4, Han CE1,5, Seong JK1; Alzheimer’s Disease Neuroimaging Initiative.

 

J Alzheimers Dis. 2017;56(4):1341-1348. doi: 10.3233/JAD-161181.

Mortality Risk after Diagnosis of Early-Onset Alzheimer's Disease versus Late-Onset Alzheimer's Disease: A Propensity Score Matching Analysis

Chang KJ11, Hong CH1,2,3, Lee KS4, Kang DR5, Lee JD5, Choi SH6, Kim SY7, Na DL8, Seo SW8, Kim DK9, Lee Y10,2, Chung YK1, Lim KY1, Noh JS1, Park J11, Son SJ1.

 

Stem Cell Rev. 2017 Feb;13(1):127-138. doi: 10.1007/s12015-016-9694-0.

Magnetic Resonance Imaging of Ferumoxytol-Labeled Human Mesenchymal Stem Cells in the Mouse Brain

Lee NK11,2,3,4, Kim HS1,2,3,4, Yoo D5, Hwang JW1,2,3,4, Choi SJ6, Oh W6, Chang JW7,8, Na DL9,10,11,12.

 

Int Psychogeriatr. 2017 Feb;29(2):227-237. doi: 10.1017/S1041610216001770. Epub 2016 Oct 26.

Influence of personality on depression, burden, and health-related quality of life in family caregivers of persons with dementia

Kim SK11, Park M1, Lee Y2, Choi SH3, Moon SY4, Seo SW5, Park KW6, Ku BD7, Han HJ8, Park KH9, Han SH10, Kim EJ11, Lee JH12, Park SA13, Shim YS14, Kim JH15, Hong CH16, Na DL5, Ye BS17, Kim HJ5, Moon Y10.

 

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):13-18. doi: 10.1097/WAD.0000000000000184.

Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea

Park SA11, Chae WS, Kim HJ, Shin HS, Kim S, Im JY, Ahn SI, Min KD, Yim SJ, Ye BS, Seo SW, Jeong JH, Park KW, Choi SH, Na DL.

 

J Neurol Sci. 2017 Jan 15;372:51-56. doi: 10.1016/j.jns.2016.11.033. Epub 2016 Nov 16.

Clinical characteristics of parkinsonism in frontotemporal dementia according to subtypes

Park HK11, Park KH2, Yoon B3, Lee JH4, Choi SH5, Joung JH6, Yoon SJ7, Kim BC8, Kim SH9, Kim EJ10, Na DL11, Park KW12.

 

Sci Rep. 2017 Jan 4;7:39340. doi: 10.1038/srep39340.

Agouti Related Peptide Secreted Via Human Mesenchymal Stem Cells Upregulates Proteasome Activity in an Alzheimer's Disease Model

Lee NK11,2,3,4, Park SE4, Kwon SJ4, Shim S5, Byeon Y4, Kim JH6, Na DL1,2,3,4, Chang JW1,4.

 

Hum Brain Mapp. 2017 Jan;38(1):165-181. doi: 10.1002/hbm.23352. Epub 2016 Sep 4.

Degree-based statistic and center persistency for brain connectivity analysis

Yoo K11,2, Lee P1,2, Chung MK3, Sohn WS1, Chung SJ4, Na DL5,6, Ju D1, Jeong Y1,2.

 

Arch Pharm Res. 2016 Aug;39(8):1171-9. doi: 10.1007/s12272-016-0799-4. Epub 2016 Aug 11.

Activin A secreted by human mesenchymal stem cells induces neuronal development and neurite outgrowth in an in vitro model of Alzheimer's disease: Neurogenesis induced by MSCs via activin A

Park SE11,2,3,4, Lee J1,5,2,3, Chang EH3,6, Kim JH7, Sung JH7, Na DL8,9,10,11, Chang JW12,13,14.

 

Neuroreport. 2016 Mar 2;27(4):235-41. doi: 10.1097/WNR.0000000000000526.

Distribution of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells in the Alzheimer's Disease Transgenic Mouse after a Single Intravenous Injection

Park SE11, Lee NK, Lee J, Hwang JW, Choi SJ, Hwang H, Hyung B, Chang JW, Na DL.

 

J Alzheimers Dis. 2016;49(2):483-91. doi: 10.3233/JAD-150556.

Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.

Ye BS11, Jang EY2, Kim SY3, Kim EJ4, Park SA5, Lee Y6, Hong CH7, Choi SH8, Yoon B9, Yoon SJ10, Na HR11, Lee JH12, Jeong JH13, Kim HJ2, Na DL2, Seo SW2,14,15.

 

PLoS One. 2016 May 20;11(5):e0155912. doi: 10.1371/journal.pone.0155912. eCollection 2016.

Intra-arterially Delivered Mesenchymal Stem Cells are not Detected in the Brain Parenchyma in an Alzheimer’s Disease Mouse Model

Lee NK11,2,3,4, Yang J5, Chang EH6, Park SE1,2,3,4, Lee J1,2,3,4, Choi SJ7, Oh W7, Chang JW1,4, Na DL2,3.

 

Front Neurosci. 2016 Sep 1;10:394. doi: 10.3389/fnins.2016.00394. eCollection 2016.

Using Individualized Brain Network for Analyzing Structural Covariance of the Cerebral Cortex in Alzheimer’s Patients

Kim HJ11, Shin JH1, Han CE1, Kim HJ2, Na DL2, Seo SW2, Seong JK1; Alzheimer's Disease Neuroimaging Initiative.

 

Sci Rep. 2016 Oct 3;6:34722. doi: 10.1038/srep34722.

Coronary artery calcium is associated with cortical thinning in cognitively normal individuals.

Lee JS11,2, Kang D3,4, Jang YK1,2, Kim HJ1,2, Na DL1,2,4, Shin HY5, Kang M5, Yang JJ6, Lee JM6, Lee J7, Kim YJ8, Park KC9, Guallar E3,10,11,12, Seo SW1,2,4,13, Cho J3,4,10,13.

 

Neurobiol Aging. 2016 Nov;47:149-156. doi: 10.1016/j.neurobiolaging.2016.08.001. Epub 2016 Aug 12.

Malignant progression in parietal-dominant atrophy subtype of Alzheimer's disease occurs independent of onset age.

Na HK11, Kang DR2, Kim S1, Seo SW3, Heilman KM4, Noh Y5, Na DL6.

 

반응형

 

 

 

J Alzheimers Dis. 2016 Oct 4;54(3):1015-1026.

The Role of Cerebrovascular Disease in Amyloid Deposition.

Noh Y11,2, Seo SW3,4,5,6, Jeon S7, Lee JM8, Kim JS9, Lee JH10, Kim JH3, Kim GH11, Ye BS12, Cho H13, Kim HJ3,4, Yoon CW14, Choe YS15, Lee KH15, Weiner MW16,17, Na DL3,4,5,18.

 

자료 출처: 메디우스 (https://medieus.com/sub_detail/doctor_detail.asp?doc_num=29337)